Navigation Links
Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
Date:5/14/2008

NEW YORK and WASHINGTON, May 14 /PRNewswire/ -- Revolution Health and EmergingMed today announced that they have teamed up to offer patients and physicians the largest personalized cancer clinical trial matching and referral service in the United States. Individuals can quickly assess their eligibility for more than 10,000 clinical trial listings in a confidential and efficient way through an online search engine or by calling a clinical trial specialist. The service, powered by EmergingMed, is offered for free on http://www.RevolutionHealth.com.

"Through our online communities, RevolutionHealth.com is helping change people's lives, giving them the information, tools and support they need to live healthier and to find key resources to help navigate the health care system when they are sick," said Brad Jacobs MD, MPH, Senior Medical Director of Revolution Health. "EmergingMed's online matching service and health call center provide key linkage points for patients and their caregivers when looking for clinical trials."

"EmergingMed is committed to providing personalized services to patients who are exploring treatment options," remarked Courtney Hudson, EmergingMed's Founder and CEO. "We believe patients should have access to the latest research options targeting their specific diagnoses. Our partnership with Revolution Health helps us reach a new, broad group of patients and families."

Revolution Health's new cancer clinical trial matching service offers both Internet-based and telephone-based service. With permission, the call center's Clinical Trial Specialists place follow-up calls to patients to ensure successful connection with a clinical trial site, address basic clinical trial questions, and provide logistical support through the search process.

To access the online search engine, type http://www.revolutionhealt
'/>"/>

SOURCE Revolution Health; EmergingMed
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. UCLA Program Aims to Revolutionize Kidney Transplants
2. U. of Md. Researchers to Develop Devices to Revolutionize Drug Research
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
6. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Tone Deafness Explained, from the Harvard Health Letter
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... NewCardio, Inc. (OTC Bulletin Board: NWCI ... Dr. Samuel George, NewCardio,s Senior Medical Advisor, will present ... dataset, conducted independently by the Cardiac Safety Research Consortium ... on December 9, 2010, at the headquarters of the ...
... The addition of Cimzia® (certolizumab pegol; CZP) to ... response, improved function and reduced disease activity in ... patients reflecting those seen in daily clinical practice ... clinical trial data were presented during the American ...
Cached Medicine Technology:NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 2NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 3NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 3New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 5New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 6New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 7New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 8New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 9New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 10
(Date:4/24/2014)... a way to sensitise cancer cells to chemotherapy - ... published today in Cell Reports , could pave ... cells that have become resistant to treatment. , The ... mechanisms behind resistance to chemotherapy drugs like Paclitaxel, often ... Andrew Gilmore, who led the research team at The ...
(Date:4/24/2014)... with the negative and stressful outcomes for parents who ... a life-limiting illness, says a recent study led by ... the challenges are numerous and life-changing and stress levels ... the Waterloo-led research reported positive outcomes as well, a ... the most recent issue of the American Journal ...
(Date:4/24/2014)... managing patients before, during and after colorectal surgery cut ... according to researchers who led a study of the ... enhanced recovery, is easier on patients before surgery, doing ... are typically prescribed. After surgery, patients are encouraged to ... to faster recoveries. , Among findings published in the ...
(Date:4/24/2014)... to be boring and irrelevant, could offer an alternative ... Researcher Dr Milena Furtado, and her team from the ... the heart cell fibroblast is a close relative to ... heart. , In research published today in Circulation ... are unique cells due to their genetic program, and ...
(Date:4/24/2014)... Depression affects more than one out of three ... study released in The Lancet Respiratory Medicine ... symptoms physically rather than mentally. , It is ... mental health and functional outcomes of critical care ... assistant professor of Medicine, and it highlights a ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Boring cells could hold the key to heart disease 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3
... March 9 (HealthDay News) -- A preliminary study reports that people ... drug just three times a week without major ill effects. ... research, and it,s not clear how much the drug would cost ... aside, the study raises the possibility that people with type 2 ...
... Boston, MA A team of researchers at Brigham ... out of every twelve adult smokers have abnormal lung ... of interstitial lung disease which is associated with substantial ... positively associated with smoking, these lung densities were inversely ...
... Nottingham could provide hope for any allergy sufferers who ... their household pet. The team of immunologists led ... of Molecular Medical Sciences, and funded by the charity ... a key role in triggering allergic responses to cat ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, March ... former-smokers develop lung conditions that reduce lung capacity, but leave ... pulmonary disease (COPD), new research shows. In fact, the ... New England Journal of Medicine found that these ...
... sheds light--both literally and figuratively--on the intricate brain ... Stanford University recently used light to activate mouse ... or decrease anxiety-related behaviors. Pinpointing the origin of ... disorders, the most common class of psychiatric disease. ...
... Satellites have been busy this week covering severe weather across ... captured an image of the huge stretch of clouds associated ... its slow march eastward. Earlier this week, NASA,s Tropical Rainfall ... tornadoes over Louisiana. Today the eastern third of ...
Cached Medicine News:Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2Health News:Researchers find smoking may increase risk for lung disease 2Health News:Nottingham scientists identify trigger in cat allergy 2Health News:Lesser Known Lung Diseases Can Strike Smokers, Ex-Smokers 2Health News:Researchers selectively control anxiety pathways in the brain 2Health News:NASA and other satellites keeping busy with this week's severe weather 2Health News:NASA and other satellites keeping busy with this week's severe weather 3Health News:NASA and other satellites keeping busy with this week's severe weather 4Health News:NASA and other satellites keeping busy with this week's severe weather 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: